Comparison of two β-D-glucan assays for detecting invasive fungal diseases in immunocompromised patients

Song, Jiwoon; Kim, Sinyoung; Park, Jungyong; Park, Younhee; Kim, Hyun Sook

doi:10.1016/j.diagmicrobio.2021.115415

Cited by 1 publication

(1 citation statement)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The diagnostic performance of Goldstream ® and Wako for IFD was compared in cases involving Candida , Aspergillus , and Pneumospora infections. Overall, the sensitivity and specificity of Goldstream ® for IFD diagnosis was lower than Wako’s (39.6% vs. 43.8%, 83.5% vs. 94.9%) [ 61 ]. However, another study using Goldstream ® measured serum BDG in 50 patients with PCP, 15 patients with candidiasis, 6 patients with chronic disseminated candidiasis, 15 patients with invasive aspergillosis, 10 patients with mucormycosis, and 40 controls.…”

Section: Introductionmentioning

confidence: 99%

Diagnosis of invasive fungal infections: challenges and recent developments

Fang¹,

et al. 2023

View full text Add to dashboard Cite

Background The global burden of invasive fungal infections (IFIs) has shown an upsurge in recent years due to the higher load of immunocompromised patients suffering from various diseases. The role of early and accurate diagnosis in the aggressive containment of the fungal infection at the initial stages becomes crucial thus, preventing the development of a life-threatening situation. With the changing demands of clinical mycology, the field of fungal diagnostics has evolved and come a long way from traditional methods of microscopy and culturing to more advanced non-culture-based tools. With the advent of more powerful approaches such as novel PCR assays, T2 Candida, microfluidic chip technology, next generation sequencing, new generation biosensors, nanotechnology-based tools, artificial intelligence-based models, the face of fungal diagnostics is constantly changing for the better. All these advances have been reviewed here giving the latest update to our readers in the most orderly flow. Main text A detailed literature survey was conducted by the team followed by data collection, pertinent data extraction, in-depth analysis, and composing the various sub-sections and the final review. The review is unique in its kind as it discusses the advances in molecular methods; advances in serology-based methods; advances in biosensor technology; and advances in machine learning-based models, all under one roof. To the best of our knowledge, there has been no review covering all of these fields (especially biosensor technology and machine learning using artificial intelligence) with relevance to invasive fungal infections. Conclusion The review will undoubtedly assist in updating the scientific community’s understanding of the most recent advancements that are on the horizon and that may be implemented as adjuncts to the traditional diagnostic algorithms.

show abstract

Section: Introductionmentioning

confidence: 99%